TY - JOUR
T1 - Tyrosine-protein kinase Yes controls endothelial junctional plasticity and barrier integrity by regulating VE-cadherin phosphorylation and endocytosis
AU - Jin, Yi
AU - Ding, Yindi
AU - Richards, Mark
AU - Kaakinen, Mika
AU - Giese, Wolfgang
AU - Baumann, Elisabeth
AU - Szymborska, Anna
AU - Rosa, André
AU - Nordling, Sofia
AU - Schimmel, Lilian
AU - Akmeriç, Emir Bora
AU - Pena, Andreia
AU - Nwadozi, Emmanuel
AU - Jamalpour, Maria
AU - Holstein, Katrin
AU - Sáinz-Jaspeado, Miguel
AU - Bernabeu, Miguel O.
AU - Welsh, Michael
AU - Gordon, Emma
AU - Franco, Claudio A.
AU - Vestweber, Dietmar
AU - Eklund, Lauri
AU - Gerhardt, Holger
AU - Claesson-Welsh, Lena
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Vascular endothelial (VE)-cadherin in endothelial adherens junctions is an essential component of the vascular barrier, critical for tissue homeostasis and implicated in diseases such as cancer and retinopathies. Inhibitors of Src cytoplasmic tyrosine kinase have been applied to suppress VE-cadherin tyrosine phosphorylation and prevent excessive leakage, edema and high interstitial pressure. Here we show that the Src-related Yes tyrosine kinase, rather than Src, is localized at endothelial cell (EC) junctions where it becomes activated in a flow-dependent manner. EC-specific Yes1 deletion suppresses VE-cadherin phosphorylation and arrests VE-cadherin at EC junctions. This is accompanied by loss of EC collective migration and exaggerated agonist-induced macromolecular leakage. Overexpression of Yes1 causes ectopic VE-cadherin phosphorylation, while vascular leakage is unaffected. In contrast, in EC-specific Src deficiency, VE-cadherin internalization is maintained and leakage is suppressed. In conclusion, Yes-mediated phosphorylation regulates constitutive VE-cadherin turnover, thereby maintaining endothelial junction plasticity and vascular integrity.
AB - Vascular endothelial (VE)-cadherin in endothelial adherens junctions is an essential component of the vascular barrier, critical for tissue homeostasis and implicated in diseases such as cancer and retinopathies. Inhibitors of Src cytoplasmic tyrosine kinase have been applied to suppress VE-cadherin tyrosine phosphorylation and prevent excessive leakage, edema and high interstitial pressure. Here we show that the Src-related Yes tyrosine kinase, rather than Src, is localized at endothelial cell (EC) junctions where it becomes activated in a flow-dependent manner. EC-specific Yes1 deletion suppresses VE-cadherin phosphorylation and arrests VE-cadherin at EC junctions. This is accompanied by loss of EC collective migration and exaggerated agonist-induced macromolecular leakage. Overexpression of Yes1 causes ectopic VE-cadherin phosphorylation, while vascular leakage is unaffected. In contrast, in EC-specific Src deficiency, VE-cadherin internalization is maintained and leakage is suppressed. In conclusion, Yes-mediated phosphorylation regulates constitutive VE-cadherin turnover, thereby maintaining endothelial junction plasticity and vascular integrity.
UR - http://www.scopus.com/inward/record.url?scp=85161153971&partnerID=8YFLogxK
U2 - 10.1038/s44161-022-00172-z
DO - 10.1038/s44161-022-00172-z
M3 - Article
C2 - 37936984
AN - SCOPUS:85161153971
SN - 2731-0590
VL - 1
SP - 1156
EP - 1173
JO - Nature Cardiovascular Research
JF - Nature Cardiovascular Research
IS - 12
ER -